Related Experiment Video
Updated: Jan 23, 2026
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Hepatectomy for huge hepatocellular carcinoma in 634 cases
Xiao-Ping Chen1, Fa-Zu Qiu, Zai-De Wu
1Hepatic Surgery Center, Tongji Hospital, Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. chenxp_53@sina.com
Aim:
To clarify the safety and feasibility of hepatectomy for huge hepatocellular carcinoma (HCC).
Methods:
A total of 4765 patients with HCC operated at Tongji Hospital were retrospectively studied, of them, 780 patients had huge HCC (10 cm or more in diameter). Hepatectomy was carried out on 634 patients (81.2%). The majority of the liver resection were major resections, and combined resection of the adjacent organs or structures was common (17.2%). The liver resection was combined with portal vein thrombectomy in 139 patients (21.9%).
Results:
Postoperative complications were common (26.8%) and required another laparotomy to prevent the complications in 5 patients (0.8%). The 30-d mortality was 2.2%. The main causes of postoperative deaths were liver failure (n = 9), postoperative bleeding (n = 4) and septic complication (n = 1). The 3-, 5- and 10-year survival rates after liver resection were 35.1%, 18.2% and 3.5%, respectively.
Conclusion:
Hepatectomy for huge HCC is safe and effective. It should be used to treat patients with low surgical risks and resectable tumours.
Related Concept Videos
01:24Biodiversity and Human Values
02:50Nuclear Fission
02:45Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
02:35Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...